stock.name

Axonics Inc

AXNX

Market Cap$3.45B
Close$

Compare Axonics

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Axonics IncAxonics Inc-216.40%-3%9.70.1
marketMarket Avg53.21.27%29%-1.3
HealthcareHealthcare Avg29.71.32%16%7.31.3
$73.82

Current Fair Value

9.3% upside

Undervalued by 9.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$3.45 Billion
Enterprise Value$3.15 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.32
Beta1.06
Outstanding Shares51,018,478
Avg 30 Day Volume463,360

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-216.43
PEG-202.91
Price to Sales9.65
Price to Book Ratio5.63
Enterprise Value to Revenue8.14
Enterprise Value to EBIT-422.19
Enterprise Value to Net Income-198
Total Debt to Enterprise0.01
Debt to Equity0.05

Revenue Sources

No data

ESG Score

No data

About Axonics ModulationTechnologies Inc

CEO: Raymond Cohen